Adial Pharmaceuticals Inc.
ADIL | NASDAQ
$4.40
-$0.46 (-9.47%)
At close: Sep 21, 2026, 4:00 PM ET
$4.48
+$0.08 (+1.82%)
After-hours:
Sep 21, 2026, 7:30 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | 141 | 141 | 282 | 282 | 282 | 282 | 141 | 141 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | -141 | -141 | -282 | -282 | -282 | -282 | -141 | -141 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -57.68M | -7.53M | -7.8M | -7.85M | -8.3M | -8.71M | -8.28M | -8.13M | -7.27M | -6.46M | -6.89M | -7.7M | -8.9M | -10.66M | -11.45M | -14.84M | -16.35M | -17.51M | -19.29M | -16.78M | -16.05M | -13.47M |
Interest Income | 195.53K | 161.28K | 149.57K | 160.71K | 163.55K | 191.2K | 178.66K | 136.12K | 95.67K | 63.69K | 69.78K | 106.38K | 99.61K | 87.12K | 63.34K | 17.72K | 17.11K | 11.36K | 6.54K | 5.69K | 5.36K | 9.36K |
Pretax Income | -57.8M | -7.77M | -7.98M | -8.05M | -8.45M | -8.95M | -13.2M | -13.03M | -12.19M | -11.24M | -7M | -7.65M | -8.85M | -10.58M | -11.25M | -14.62M | -16.39M | -17.59M | -19.52M | -17.06M | -16.08M | -13.45M |
Net Income | -57.8M | -7.77M | -7.98M | -8.05M | -8.45M | -8.95M | -13.2M | -13.05M | -12.24M | -8.69M | -5.12M | -6.07M | -7.79M | -12.73M | -12.73M | -15.7M | -16.9M | -17.5M | -19.42M | -17.06M | -16.08M | -13.45M |
Selling & General & Admin | 9.48M | 5.23M | 5.18M | 5.12M | 5.06M | 5.18M | 5.05M | 5.36M | 5.34M | 5.11M | 5.62M | 6.17M | 6.87M | 8.39M | 8.95M | 8.94M | 9.45M | 8.97M | 9.3M | 8.65M | 7.77M | 6.62M |
Research & Development | 2.01M | 2.31M | 2.62M | 2.73M | 3.24M | 3.52M | 3.23M | 2.76M | 1.94M | 1.36M | 1.27M | 1.53M | 2.02M | 2.27M | 2.5M | 4.31M | 5.3M | 6.94M | 8.4M | 8.13M | 8.28M | 6.85M |
Other Expenses | 46.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | 1.59M | 1.59M | 1.59M | 1.59M | 0 | n/a | 0 |
Operating Expenses | 57.68M | 7.53M | 7.8M | 7.85M | 8.3M | 8.71M | 8.28M | 8.13M | 7.27M | 6.46M | 6.89M | 7.7M | 8.9M | 10.66M | 11.45M | 14.84M | 16.35M | 17.51M | 19.29M | 16.78M | 16.05M | 13.47M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14.89K | 14.89K | 14.89K | 14.89K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -141 | -141 | -141 | -141 | n/a | n/a | n/a | n/a | n/a | 19.38K | 38.4K | 60.63K | 79.58K | 78.41K | 59.38K | 37.15K | 18.21K |
Cost & Expenses | 57.68M | 7.53M | 7.8M | 7.85M | 8.3M | 8.71M | 8.28M | 8.13M | 7.27M | 6.46M | 6.89M | 7.7M | 8.9M | 10.66M | 11.45M | 14.84M | 16.35M | 17.51M | 19.29M | 16.78M | 16.05M | 13.47M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -94.08K | -94.08K | -94.08K | -94.08K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 4.62M | 1.37M | 1.11M | 886.85K | 424.91K | 743.55K | 743.55K | 233.43K | 167.31K | 118.16K | 66.54K | 47.14K | 45.26K | 42.34K | 42.7K | 41.16K | 38.91K | 37.04K | 32.85K | 31.76K | 28.14K | 25.46K |
Shares Outstanding (Diluted) | 4.62M | 1.37M | 1.11M | 886.85K | 424.91K | 743.55K | 743.55K | 233.43K | 167.31K | 118.16K | 66.54K | 47.14K | 45.26K | 42.34K | 42.7K | 41.16K | 38.91K | 37.04K | 33.22K | 31.76K | 28.14K | 25.46K |
EPS (Basic) | -16.53 | -9.78 | -16.80 | -17.75 | -25.25 | -35.50 | -81.75 | -107.75 | -127.75 | -89 | -102.50 | -141 | -185.25 | -308.50 | -314.75 | -425 | -487.25 | -545.75 | -661 | -634.25 | -651 | -593.50 |
EPS (Diluted) | -16.53 | -9.78 | -16.80 | -17.75 | -25.25 | -35.50 | -81.75 | -107.75 | -127.75 | -89 | -102.50 | -141 | -185.25 | -308.50 | -314.75 | -423 | -485.25 | -543.75 | -659 | -634.25 | -651 | -593.50 |
EBITDA | -57.8M | -7.77M | -7.98M | -8.05M | -8.45M | -8.95M | -13.2M | -13.03M | -12.19M | -11.24M | -7M | -7.65M | -8.85M | -10.58M | -11.24M | -13.07M | -14.84M | -16.05M | -17.98M | -17.07M | -16.09M | -13.47M |
EBIT | -57.8M | -7.77M | -7.98M | -8.05M | -8.45M | -8.95M | -13.2M | -13.03M | -12.19M | -11.24M | -7M | -7.65M | -8.85M | -10.58M | -11.25M | -13.08M | -14.85M | -16.05M | -17.99M | -17.07M | -16.09M | -13.47M |
Depreciation & Amortization | 424 | 565 | 565 | 564 | 565 | 565 | 565 | 565 | 564 | 564 | 564 | 564 | 564 | 2.5K | 4.43K | 8.29K | 8.29K | 8.29K | 7.02K | 3.16K | 3.16K | 1.23K |
Add to Watchlist
Select watchlists to add or remove ADIL